BAJAJ BROKING

Notification
No new Notification messages
Nisus Finance Services IPO is Open!
Apply for the Nisus Finance Services IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
gufic biosciences ltd. stock

GUFIC BIOSCIENCES LTD. Share Price

445.1 -1.64 (-0.36%)
Dec 04 2024 03:30 PM Pharmaceuticals NSE: GUFICBIO

GUFIC BIOSCIENCES LTD. Share Price Update

As of the latest trading session, GUFIC BIOSCIENCES LTD. share price is currently at 445.1, which is down by -1.64 from its previous closing. Today, the stock has fluctuated between 439.50 and 459.85. Over the past year, GUFIC BIOSCIENCES LTD. has achieved a return of 34.58 %. In the last month alone, the return has been -4.01 %. Read More...

GUFIC BIOSCIENCES LTD. Performance

Day Range

Low439.50 High459.85
445.10

52 Week Range

Low 277.65 High 504.25
445.10

GUFIC BIOSCIENCES LTD. Share Price

11606

509079

GUFICBIO

img img img img
No Data Available

Open Price

454.00

Prev. Close

446.75

Volume (Shares)

166039.00

Total traded value

739.03

Upper Circuit

536.10

Lower Circuit

357.40

Note: The current prices & values are delayed, Login to your account for live updates.

GUFIC BIOSCIENCES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 4463.35
PE Ratio (TTM) 52.74
Book Value / Share 57.26
Beta 0.59
ROE 19.57%
EPS (TTM) 8.47
Dividend Yield 0.02%
Net Profit Qtr (Cr) 21.78

GUFIC BIOSCIENCES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 204.18
Operating Expense 175.03
Net Profit 21.78
Net Profit Margin (%) 10.66
Earnings Per Share (EPS) 2.17
EBITDA 38.73
Effective Tax Rate (%) 25.59
Particulars JUN 2024 (Values in Cr)
Revenue 202.81
Operating Expense 175.96
Net Profit 20.86
Net Profit Margin (%) 10.28
Earnings Per Share (EPS) 2.08
EBITDA 37.04
Effective Tax Rate (%) 25.79
Particulars MAR 2024 (Values in Cr)
Revenue 194.99
Operating Expense 168.76
Net Profit 20.05
Net Profit Margin (%) 10.28
Earnings Per Share (EPS) 2.00
EBITDA 35.11
Effective Tax Rate (%) 26.06
Particulars DEC 2023 (Values in Cr)
Revenue 201.78
Operating Expense 172.64
Net Profit 22.26
Net Profit Margin (%) 11.03
Earnings Per Share (EPS) 2.23
EBITDA 36.88
Effective Tax Rate (%) 24.69
Particulars SEP 2023 (Values in Cr)
Revenue 214.87
Operating Expense 184.26
Net Profit 23.21
Net Profit Margin (%) 10.80
Earnings Per Share (EPS) 2.39
EBITDA 39.70
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 806.67
Operating Expense 693.17
Net Profit 86.14
Net Profit Margin (%) 10.67
Earnings Per Share (EPS) 8.74
EBITDA 148.05
Effective Tax Rate (%) 25.53
Particulars MAR 2023 (Values in Cr)
Revenue 690.62
Operating Expense 586.47
Net Profit 79.70
Net Profit Margin (%) 11.54
Earnings Per Share (EPS) 8.22
EBITDA 137.22
Effective Tax Rate (%) 25.31
Particulars MAR 2022 (Values in Cr)
Revenue 779.16
Operating Expense 655.43
Net Profit 95.84
Net Profit Margin (%) 12.30
Earnings Per Share (EPS) 9.89
EBITDA 151.14
Effective Tax Rate (%) 24.44
Particulars MAR 2021 (Values in Cr)
Revenue 487.70
Operating Expense 433.71
Net Profit 44.23
Net Profit Margin (%) 9.06
Earnings Per Share (EPS) 4.56
EBITDA 87.65
Effective Tax Rate (%) 23.35
Particulars MAR 2020 (Values in Cr)
Revenue 378.84
Operating Expense 354.50
Net Profit 22.69
Net Profit Margin (%) 5.98
Earnings Per Share (EPS) 2.34
EBITDA 57.90
Effective Tax Rate (%) 24.69
Particulars MAR 2024 (Values in Cr)
Book Value / Share 53.11
ROE % 16.17
ROCE % 14.79
Total Debt to Total Equity 0.63
EBITDA Margin 18.35
Particulars MAR 2024 (Values in Cr)
Book Value / Share 53.11
ROE % 19.57
ROCE % 16.52
Total Debt to Total Equity 0.76
EBITDA Margin 18.35
Particulars MAR 2023 (Values in Cr)
Book Value / Share 35.88
ROE % 25.84
ROCE % 21.87
Total Debt to Total Equity 0.65
EBITDA Margin 19.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 27.76
ROE % 43.31
ROCE % 43.99
Total Debt to Total Equity 0.28
EBITDA Margin 19.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 17.89
ROE % 29.22
ROCE % 27.51
Total Debt to Total Equity 0.62
EBITDA Margin 17.97
Particulars MAR 2020 (Values in Cr)
Book Value / Share 13.34
ROE % 22.17
ROCE % 19.66
Total Debt to Total Equity 1.10
EBITDA Margin 15.28
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.48
Total Assets 1092.54
Total Liabilities 1092.54
Total Equity 532.56
Share Outstanding 100277506
Price to Book Ratio 5.33
Return on Assets (%) 7.88
Return on Capital (%) 10.14
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.47
Total Assets 1092.54
Total Liabilities 1092.54
Total Equity 532.56
Share Outstanding 100277506
Price to Book Ratio 5.33
Return on Assets (%) 7.88
Return on Capital (%) 10.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 46.68
Total Assets 861.15
Total Liabilities 861.15
Total Equity 347.80
Share Outstanding 96944506
Price to Book Ratio 5.20
Return on Assets (%) 9.25
Return on Capital (%) 12.09
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 26.57
Total Assets 521.40
Total Liabilities 521.40
Total Equity 269.11
Share Outstanding 96944506
Price to Book Ratio 8.97
Return on Assets (%) 18.38
Return on Capital (%) 29.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 13.17
Total Assets 392.06
Total Liabilities 392.06
Total Equity 173.43
Share Outstanding 96944506
Price to Book Ratio 6.39
Return on Assets (%) 11.28
Return on Capital (%) 19.33
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 16.37
Total Assets 407.51
Total Liabilities 407.51
Total Equity 129.32
Share Outstanding 96944506
Price to Book Ratio 3.53
Return on Assets (%) 5.56
Return on Capital (%) 9.38
Particulars MAR 2024 (Values in Cr)
Net Income 86.13
Cash from Operations 19.58
Cash from Investing -102.38
Cash from Financing 82.38
Net change in Cash -27.46
Free Cash Flow 19.58
Particulars MAR 2024 (Values in Cr)
Net Income 86.13
Cash from Operations 19.58
Cash from Investing -102.39
Cash from Financing 82.38
Net change in Cash -27.47
Free Cash Flow 19.58
Particulars MAR 2023 (Values in Cr)
Net Income 79.70
Cash from Operations 1.10
Cash from Investing -190.72
Cash from Financing 234.30
Net change in Cash 16.99
Free Cash Flow 1.10
Particulars MAR 2022 (Values in Cr)
Net Income 95.84
Cash from Operations 139.29
Cash from Investing -94.58
Cash from Financing -6.24
Net change in Cash 5.40
Free Cash Flow 139.29
Particulars MAR 2021 (Values in Cr)
Net Income 44.23
Cash from Operations 96.65
Cash from Investing -6.69
Cash from Financing -78.61
Net change in Cash 1.94
Free Cash Flow 109.05
Particulars MAR 2020 (Values in Cr)
Net Income 22.68
Cash from Operations 57.23
Cash from Investing -42.53
Cash from Financing -4.20
Net change in Cash 0.36
Free Cash Flow 97.08
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 33.57 3.18 447.69 37.54 / 77.70
BLISS GVS PHARMA LTD 163.60 20.48 1.70 1722.74 92.25 / 172.40
CIPLA LTD 1534.40 26.84 4.36 123920.06 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.85 141.27 4.12 1197.40 145.00 / 413.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 50.80 9.93 447.69 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.60 45.60 7.27 2167.14 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6597.95 128.14 24.28 16494.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 163.60 21.30 1.68 1722.74 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 423.80
  • 26 Days 429.80
  • 10 Days 418.50
  • 50 Days 422.70
  • 12 Days 422.10
  • 100 Days 404.50
  • 20 Days 428.60
  • 200 Days 331.70
437.27
PIVOT
First Resistance 464.48
Second Resistance 482.22
Third Resistance 509.43
First Support 419.53
Second Support 392.32
Third Support 374.58
RSI 57.00
MACD -7.70
Commodity Channel Index (CCI) 1.02
ADX 18.23
Williams % R -46.59

Over 1 Month

down

-4.01

Over 3 Months

down

13.48

Over 6 Months

down

41.93

Over 1 Year

down

34.58

Over 3 Years

down

33.23

Over 5 Years

down

45.84

GUFIC BIOSCIENCES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GUFIC BIOSCIENCES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
24.74
Promoter Holdings
72.5
FII
0.23
DII
2.51
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Jayesh Pannalal Choksi Shareholding of Promoter and Promoter Group 2.4690829E7 24.62
Zircon Teconica Private Limited Shareholding of Promoter and Promoter Group 2.052333E7 20.47
Gufic Private Limited Shareholding of Promoter and Promoter Group 1.0191523E7 10.16
Vipula Jayesh Choksi Shareholding of Promoter and Promoter Group 1.0033843E7 10.01
Pranav Jayesh Choksi Shareholding of Promoter and Promoter Group 7268626.0 7.25
Motilal Oswal Financial Services Ltd Public Shareholding 3333000.0 3.32
Jagdish N Master Public Shareholding 1527500.0 1.52
Motilal Oswal Small Cap Fund Public Shareholding 1053787.0 1.05

GUFIC BIOSCIENCES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-21 0.1 Final 2023-09-21 Equity shares 2022-08-24 0.1 Final 2022-08-25 Equity shares 2021-09-09 0.1 Final 2021-09-14 Equity shares 2020-11-03 0.05 Final 2020-11-05 Equity shares 2019-09-20 0.05 Final 2019-09-24 Equity shares 2018-09-19 0.05 Final 2018-09-22 Equity shares 2017-08-28 0.05 Final 2017-08-30 Equity shares 2016-09-19 0.05 Final 2016-09-21 Equity shares 2015-09-22 0.05 Final 2015-09-24 Equity shares 2014-09-18 0.05 Final 2014-09-22 Equity shares 2013-09-02 0.05 Final 2013-09-23 Equity shares 2012-08-16 0.05 Final 2012-08-20 Equity shares 2011-09-16 0.05 Final 2011-09-20 Equity shares 2010-09-20 0.05 Final 2010-09-22 Equity shares 2009-09-17 0.05 Final 2009-09-19 Equity shares 2008-12-11 0.05 Final 2008-12-15 Equity shares 2008-03-19 0.05 Final 2008-03-25 Equity shares 2006-09-20 0.0 Final 2006-09-22 Equity shares 2005-09-22 0.0 Final 2005-09-24 Equity shares
Ex-Date Ex-Bonus Ratio
2000-11-04 2000-10-19 5:2 2000-11-04 2000-10-09 5:2
Ex-Date Old FV NEW FV Record Date
2002-10-29 10.0 1.0 2002-11-08

Learn More About Stocks

About GUFIC BIOSCIENCES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GUFIC BIOSCIENCES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Gufic BioSciences Ltd?

Answer Field

The share price of Gufic BioSciences Ltd for NSE is ₹ 445.1 and for BSE is ₹ 448.8.

What is the Market Cap of Gufic BioSciences Ltd?

Answer Field

The market cap of Gufic BioSciences Ltd for NSE is ₹ 44,63.35 Cr. and for BSE is ₹ 45,00.45 Cr. as of now.

What is the 52 Week High and Low of Gufic BioSciences Ltd?

Answer Field

The 52 Week High and Low of Gufic BioSciences Ltd for NSE is ₹ 504.25 and ₹ 277.65 and for BSE is ₹ 501.10 and ₹ 278.00.

How to Buy Gufic BioSciences Ltd share?

Answer Field

You can trade in Gufic BioSciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Gufic BioSciences Ltd?

Answer Field

The 1 year returns on the stock has been 34.58%.

What is the Current Share Price of Gufic BioSciences Ltd?

Answer Field

Gufic BioSciences Ltd share price is for NSE ₹ 445.1 & for BSE ₹ 448.8 as on Dec 04 2024 03:30 PM.

What is the Market Cap of Gufic BioSciences Ltd Share?

Answer Field

The market cap of Gufic BioSciences Ltd for NSE ₹ 44,63.35 & for BSE ₹ 45,00.45 as on Dec 04 2024 03:30 PM.

What is the P/E Ratio of Gufic BioSciences Ltd Share?

Answer Field

As on Dec 04 2024 03:30 PM the price-to-earnings (PE) ratio for Gufic BioSciences Ltd share is 52.74.

What is the PB ratio of Gufic BioSciences Ltd Share?

Answer Field

As on Dec 04 2024 03:30 PM, the price-to-book (PB) ratio for Gufic BioSciences Ltd share is 57.26.

How to Buy Gufic BioSciences Ltd Share?

Answer Field

You can trade in Gufic BioSciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gufic BioSciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Gufic BioSciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gufic BioSciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader